Clinical Trial Update: Therapeutic Drug Monitoring of Ixekizumab in Psoriasis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on therapeutic drug monitoring of ixekizumab in patients with psoriasis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Ixekizumab (ixekizumab)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Psoriasis Vulgaris | Phase 4 | Status: COMPLETED